Most of you know that PCYC was acquired for $261.25 in 2015. But you might not know that their stock dropped to $0.55 after clinical setback and company reorganization in 2008. Three months later the stock doubled to $1.05 on positive trial data, which led to partnership with J&J. The rest is history.
B-UP just annouced positive data. B-OM and P should have top-line data in 3-4 months. I'm not saying IPIX is PCYC right now, but I do believe IPIX has higher potential. One partnership will change the company and they have multiple shots on goal. Hang in there guys.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links